ANI Pharmaceuticals Inc (ANIP) stock
ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3048% below fair value
$69.99−0.90 (-1.27%)
Close on Nov 17, 2026Market cap $1.61BP/E 14.9Yield –
ANI Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
ANI Pharmaceuticals's pe ratio was 14.4× on Nov 11, 2026, against 52.1× a year earlier. Over the last 5 years it ranged from 14.4× to 173.7×, with a median of 60.6×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 14.4× | −34.0 |
| 2025 | Dec 31, 2025 | 48.4× | −0.5 |
| 2024 | Oct 31, 2024 | 48.9× | −57.1 |
| 2023 | Dec 29, 2023 | 106.0× | +26.0 |
| 2020 | Apr 30, 2020 | 80.0× | +34.3 |
| 2019 | Dec 31, 2019 | 45.7× | −59.3 |
| 2018 | Jan 31, 2018 | 104.9× | +4.2 |
| 2017 | Dec 29, 2017 | 100.7× | +12.8 |
| 2016 | Dec 30, 2016 | 87.9× | +72.3 |
| 2015 | Dec 31, 2015 | 15.6× | – |
See a number that looks wrong?